Editorial Board — Medscape Neurology

Board Members

 

Board Member Details

Mark J. Alberts, MD
Mark J. Alberts, MD

Professor, Department of Neurology, University of Connecticut; Chief, Department of Neurology, Hartford Hospital, Hartford, Connecticut

Mark J. Alberts, MD, has disclosed the following relevant financial relationships:
Serve(d) as a director, officer, partner, employee, advisor, consultant, or trustee for: Portola; Bristol-Myers Squibb; Pfizer; Genentech; Janssen; Boehringer-Ingelheim
Serve(d) as a speaker or a member of a speakers bureau for: Portola; Bristol-Myers Squibb; Pfizer; Genentech; Janssen; Boehringer-Ingelheim
Receives royalties for: Athena Neuroscience

Charles E. Argoff, MD
Charles E. Argoff, MD

Professor, Department of Neurology, Albany Medical College; Director, Comprehensive Pain Center and Pain Management Fellowship, Albany Medical Center, Albany, New York

Charles E. Argoff, MD, has disclosed the following relevant financial relationships:
Serve(d) as a director, officer, partner, employee, advisor, consultant, or trustee for: Pfizer; Eli Lilly; Vertex; BDSI; Flowonix; Collegium; Kaleo; Teva; Shonoghi; Clexio
Serve(d) as a speaker or a member of a speakers bureau for: Teva; Amgen; Novartis; Eli Lilly; DSI; Scilex; Allergan; Tercera
Received research grant from: Grunenthal

Hans-Christoph Diener, MD, PhD

Senior Professor for Clinical Neurosciences, Department of Neurology, University Hospital Essen, University Duisburg-Essen, Institute for Medical Informatic, Biometry and Epidemiology, Hufelandstrasse, Essen, Germany

Hans-Christoph Diener, MD, PhD, has disclosed the following relevant financial relationships:
Received honoraria for participation in clinical trials, contribution to advisory boards or oral presentations from: Abbott; Achelios; Allergan; AstraZeneca; Bayer Vital; Bristol-Myers Squibb; Boehringer Ingelheim; CoAxia; Corimmun; Covidien; Daiichi-Sankyo; D-Pharm; Frensius; GlaxoSmithKline; Janssen-Cilag; Johnson & Johnson; Knoll; Eli Lilly; MSD; Medtronic; MindFrame; Neurobiological Technologies; Novartis; Novo Nordisk; Paion; Parke-Davis; Pfizer; Portola; Sanofi-Aventis; Schering-Plough; Servier; Solvay; St. Jude; Syngis; Talecris; Thrombogenics; WebMD Global; Wyeth and Yamanouchi;
Received financial support for research projects from: AstraZeneca; GSK; Boehringer Ingelheim; Lundbeck; Novartis; Janssen-Cilag; Sanofi-Aventis; Syngis and Talecris
The Department of Neurology at the University Duisburg-Essen received research grants from: The German Research Council (DFG); German Ministry of Education and Research (BMBF); European Union; NIH; Bertelsmann Foundation; Heinz-Nixdorf Foundation
Serve(d) as editor of: Aktuelle Neurologie; Arzneimitteltherapie; Kopfschmerznews; Stroke News; Cephalalgia
Serve(d) on the editorial board for: Lancet Neurology; Stroke; European Neurology; Cerebrovascular Disorders

Randolph W. Evans, MD
Randolph W. Evans, MD

Clinical Professor, Department of Neurology, Baylor College of Medicine, Houston, Texas

Randolph W. Evans, MD, has disclosed the following relevant financial relationships:
Serve(d) as a director, officer, partner, employee, advisor, consultant, or trustee for: Alder; Egalet; Promius
Serve(d) as a speaker or a member of a speakers bureau for: Allergan; Amgen; electroCore; Eli Lilly; Novartis; Promius; Teva

Mark Freedman, MD
Mark Freedman, MD

Mark S. Freedman, MSc, MD, Professor of Medicine (Neurology), University of Ottawa and The Ottawa Hospital Research Institute; Director, Multiple Sclerosis Research Unit, The Ottawa Hospital – General Campus, Ottawa, Ontario

Mark S. Freedman, MSc, MD, has disclosed the following relevant financial relationships:
Serve(d) as an advisor for: Actelion Pharmaceuticals, Ltd; Bayer HealthCare Pharmaceuticals; Biogen Idec Inc.; Clene Nanomedicine; EMD Inc.; Genzyme Corporation; F. Hoffman La-Roche Ltd; Merck & Co., Inc.; MedDay Pharmaceuticals; Novartis Pharmaceuticals Corporation; sanofi-aventis; Teva Pharmaceutical Industries
Serve(d) as a speaker or a member of a speakers bureau for: Genzyme Corporation
Received research and educational grants from: Genzyme Corporation
Received honoraria or consultation fees from: Actelion Pharmaceuticals, Ltd; Bayer HealthCare Pharmaceuticals; Biogen Idec Inc.; Chugai Pharma USA, LLC; Clene Nanomedicine; EMD Inc.; Genzyme Corporation; Merck & Co., Inc.; Novartis Pharmaceuticals Corporation; F. Hoffman La-Roche Ltd; sanofi-aventis; Teva Pharmaceutical Industries

Richard S. Isaacson, MD
Richard S. Isaacson, MD

Associate Professor, Assistant Dean of Faculty Development, Department of Neurology, Weill Cornell Medicine, New York, New York

Richard S. Isaacson, has disclosed no relevant financial relationships.

Helmi L. Lutsep, MD
Helmi L. Lutsep, MD

Professor and Vice Chair, Department of Neurology, Oregon Health & Science University; Chief of Neurology, VA Portland Health Care System, Portland, Oregon

Helmi L. Lutsep, MD, has disclosed the following relevant financial relationships:
Serve(d) as a consultant for: Abbott Vascular, Inc.
Serve(d) on the Stroke Adjudication Committee for: CREST2 trial; NINDS/Mayo
Serve(d) as a National Leader and on the Steering Committee for: AXIOMATIC-SSP trial; Bristol Myers Squib
Serve(d) on the Physician Advisory Board for: Coherex Medical
Serve(d) on the Editorial Board for: Medscape Neurology

Thomas Roth, PhD
Thomas Roth, PhD

Professor, Department of Psychiatry, Wayne State Medical School; Director, Sleep Disorders and Research Center, Henry Ford Hospital, Detroit, Michigan

Thomas Roth, PhD, has disclosed the following relevant financial relationships:
Serve(d) as a director, officer, partner, employee, advisor, consultant, or trustee for: Merck; Avadel; Idorsia; Sanovion; Sanofi

Stephen D. Silberstein, MD
Stephen D. Silberstein, MD

Professor, Department of Neurology, Thomas Jefferson University; Director, Jefferson Headache Center, Philadelphia, Pennsylvania

Stephen D. Silberstein, MD, has disclosed the following relevant financial relationships:
Received honoraria for serving as a consultant and/or advisory panel member for: Abide Therapeutics; Alder; Allergan; Amgen; Avanir; Biohaven; Cefaly; Curelator; Dr. Reddy's Laboratories;
Egalet Corporation; GlaxoSmithKline; eNeura; electroCore; Impel NeuroPharma; Eli Lilly; Medscape; Novartis; Satsuma; Supernus; Teva; Tehranica; Trigemina

Michael J. Thorpy, MD
Michael J. Thorpy, MD

Professor of Neurology, Albert Einstein College of Medicine; Director, Sleep-Wake Disorder Center, Montefiore Medical Center, Bronx, New York

Michael J. Thorpy, MD, has disclosed the following relevant financial relationships:
Received research grant from: Jazz; Avadel; Balance; Aysome

Andrew N. Wilner, MD
Andrew N. Wilner, MD

Associate Professor of Neurology, University of Tennessee Health Science Center, University of Tennessee; Staff Neurologist, Regional One Health, Memphis, Tennessee

Andrew N. Wilner, MD, has disclosed the following relevant financial relationships:
Serve(d) as Medical Advisor for: Accordant Health Services; CVS Health
Serve(d) as a consultant for: UCB Pharma
Received income in an amount equal to or greater than $250 from: Neurology Times; Neurology Review; ReachMD.com